VAERS Explorer
Back to explore

Report #2860294

Received Sep 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NC
Recovered
Unknown
Vaccinated
Jul 1, 2025
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATIONUNK—IM

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

5 1/2 Weeks Since I had the First Dose of HEPLISAV-B; Initial report received on 27-Aug-2025. A pharmacist reported that she, a 58-year-old female, received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization five and a half weeks ago and has not had the second dose. No medical history or concomitant medications were reported. In approximately Jul-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, and site not available)] intramuscularly. On 27-Aug-2025, five and a half weeks after receiving HEPLISAV-B, the patient had not received the second dose of HEPLISAV-B yet. No other information was available per the reporter. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.